Magazine Article | July 1, 2021

The Collective Benefits Of A Collaborative CFO

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

First, the differences. BioDelivery Sciences International (BDSI), where Terry Coelho is an EVP and the CFO, is not like the companies our readers typically occupy.

Most of those are profitless biopharma enterprises bravely developing new drugs or drug devices not yet approved for marketing. BDSI is a profitable, commercial company selling two drug products but no longer discovering or developing any new ones. Rather than a head of R&D, the company has a chief commercial officer; most employees are in sales, and operations are geared to the market.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: